BioCentury
ARTICLE | Company News

Management tracks: Coles to lead Cerevel; plus Genfit, Jubilant, Paratek, Mogrify, Dementia Discovery Fund and Ayala

September 9, 2019 11:49 PM UTC

Cerevel Therapeutics LLC (Boston, Mass.) hired Tony Coles as CEO. Coles is Cerevel’s executive chairman as well as the co-founder and executive chairman of neurodegeneration company Yumanity Therapeutics LLC (Cambridge, Mass.), where he was until recently CEO (see “Coles Picks Peters to Lead Company”).

Coles was chairman and CEO of Onyx Pharmaceuticals Inc., prior to its 2013 acquisition by Amgen Inc. (NASDAQ:AMGN) for $10.4 billion...